Naltrexone in the treatment of pathological gambling and alcohol dependence
Crockford, D.N.; el-Guebaly, N.
Canadian Journal of Psychiatry. Revue Canadienne de Psychiatrie 43(1): 86
1998
ISSN/ISBN: 0706-7437 PMID: 9494755 Document Number: 497734
Document emailed within 1 workday
Related Documents
Lahti, T.; Halme, J.T.; Pankakoski, M.; Sinclair, D.; Alho, H. 2010: Treatment of pathological gambling with naltrexone pharmacotherapy and brief intervention: a pilot study Psychopharmacology Bulletin 43(3): 35-44Bieńkowski, P.ła. 2013: Pharmacological features of naltrexone and its use in the treatment of alcohol dependence Psychiatria Polska 47(1): 117-126
Ochoa Mangado, E.; Arias Horcajadas, F. 2000: Alcohol consumption in opioid-dependence patients in treatment with naltrexone Actas Espanolas de Psiquiatria 28(4): 239-249
Namkoong, K.; Farren, C.K.; O'Connor, P.G.; O'Malley, S.S. 1999: Measurement of compliance with naltrexone in the treatment of alcohol dependence: research and clinical implications Journal of Clinical Psychiatry 60(7): 449-453
Galarza, N.J.; Díaz Ramírez, D.; Guzmán, F.; Caballero, J.A.; Martínez, A.J. 1997: The use of naltrexone to treat ambulatory patients with alcohol dependence Boletin de la Asociacion Medica de Puerto Rico 89(10-12): 157-160
Kato, H. 2008: Pharmacological effects of a mu-opioid receptor antagonist naltrexone on alcohol dependence Nihon Arukoru Yakubutsu Igakkai Zasshi 43(5): 697-704
Grant, J.E.; Potenza, M.N. 2010: Pharmacological treatment of adolescent pathological gambling International Journal of Adolescent Medicine and Health 22(1): 129-138
Zimmerman, M.; Breen, R.B.; Posternak, M.A. 2002: An open-label study of citalopram in the treatment of pathological gambling Journal of Clinical Psychiatry 63(1): 44-48
Laramée, P.; Millier, Aélie.; Brodtkorb, T-Henrik.; Rahhali, N.; Cristeau, O.; Aballéa, S.; Montgomery, S.; Steeves, S.; Toumi, M.; Rehm, Jürgen. 2016: A Comparison of Markov and Discrete-Time Microsimulation Approaches: Simulating the Avoidance of Alcohol-Attributable Harmful Events from Reduction of Alcohol Consumption Through Treatment of Alcohol Dependence Clinical Drug Investigation 36(11): 945-956
Schottenfeld, R.S.; Chawarski, M.C.; Mazlan, M. 2008: Maintenance treatment with buprenorphine and naltrexone for heroin dependence in Malaysia: a randomised, double-blind, placebo-controlled trial Lancet 371(9631): 2192-2200
Potenza, M.N. 2001: The neurobiology of pathological gambling Seminars in Clinical Neuropsychiatry 6(3): 217-226
McConaghy, N. 1988: Assessment and management of pathological gambling British Journal of Hospital Medicine 40(2): 131; 133-135
Winslow, M.; Subramaniam, M.; Qiu, S.; Lee, A. 2010: Socio-demographic profile and psychiatric comorbidity of subjects with pathological gambling Annals of the Academy of Medicine Singapore 39(2): 122-128
Cibin, M.; Gentile, N.; Ferri, M.; Gallimberti, L. 1989: Naltrexone and prevention of opiate dependence relapse. An Italian experience Minerva Psichiatrica 30(2): 93-98
Liffredo, C.; Gallino, G. 1993: Naltrexone in the therapeutic relation in cases of opioid abuse and dependence Minerva Medica 84(12): 687-692
Daeppen, J.-B. 2011: Towards a personalized treatment of alcohol dependence Revue Medicale Suisse 7(302): 1443
Saito, T. 2010: Status and treatment of alcohol dependence associated with mental disorders Seishin Shinkeigaku Zasshi 112(8): 764-765
Miyakawa, T.; Maesato, H.; Higuchi, S. 2005: The treatment cost at different stages of alcohol dependence in Japan Nihon Arukoru Yakubutsu Igakkai Zasshi 40(3): 181-190
Hiles, F.M. 1987: Prevention and treatment of alcohol dependence in the Royal Navy British Journal of Clinical Practice. Supplement 51: 32-35
Sivolap, I.P. 2014: Treatment of alcohol dependence: rational and arguable approaches Zhurnal Nevrologii i Psikhiatrii Imeni S.S. Korsakova 114(5 Part 2): 53-56